Atezolizumab Can Induce Response in Alveolar Soft Part Sarcoma
THURSDAY, Sept. 7, 2023 (HealthDay News) — The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the Sept. 7 issue of the New…
Learn MoreHepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
THURSDAY, Sept. 7, 2023 (HealthDay News) — The leading cause of hepatocellular carcinoma (HCC) is still hepatitis C virus (HCV) among men, but the rates of HCV-HCC have decreased since 2015, according to a study published online Sept. 5 in Clinical G…
Learn MoreEarly-Onset Cancer Morbidity Continuing to Increase
THURSDAY, Sept. 7, 2023 (HealthDay News) — Early-onset cancer morbidity is continuing to increase worldwide, according to a study published online Sept. 5 in BMJ Oncology.Jianhui Zhao, from Zhejiang University School of Medicine in China, and colleag…
Learn MoreOpioid-Free Discharge Feasible After Pancreatectomy
THURSDAY, Sept. 7, 2023 (HealthDay News) — Opioid-free discharge is feasible after pancreatic surgery, according to a study published online Sept. 6 in JAMA Surgery.Artem Boyev, D.O., from The University of Texas MD Anderson Cancer Center in Houston,…
Learn MoreOpioid-Free Discharge Feasible After Pancreatectomy
THURSDAY, Sept. 7, 2023 (HealthDay News) — Opioid-free discharge is feasible after pancreatic surgery, according to a study published online Sept. 6 in JAMA Surgery.Artem Boyev, D.O., from The University of Texas MD Anderson Cancer Center in Houston,…
Learn MoreIn Situ, Invasive Melanoma Diagnoses Decreased in 2020
THURSDAY, Sept. 7, 2023 (HealthDay News) — During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology.Daniel Y. Kim, from Harvard Medical School, and…
Learn MoreIn Situ, Invasive Melanoma Diagnoses Decreased in 2020
THURSDAY, Sept. 7, 2023 (HealthDay News) — During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology.Daniel Y. Kim, from Harvard Medical School, and…
Learn MoreStatin Use Linked to Reduced Risk for CRC Incidence, Mortality in Patients With IBD
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with inflammatory bowel disease (IBD), statin use is associated with a reduced risk for colorectal cancer (CRC) incidence and mortality, according to a study published online Aug. 24 in eClinica…
Learn MoreStatin Use Linked to Reduced Risk for CRC Incidence, Mortality in Patients With IBD
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with inflammatory bowel disease (IBD), statin use is associated with a reduced risk for colorectal cancer (CRC) incidence and mortality, according to a study published online Aug. 24 in eClinica…
Learn MoreNew Test Could Spot a Tough-to-Detect Cervical Cancer
THURSDAY, Sept. 7, 2023 (HealthDay News) — A new test detects a type of cervical cancer often missed by a standard Pap test, providing an important advance in detection.The test was developed by scientists at Montefiore Einstein Cancer Center in New …
Learn More